Orthocell receives US FDA 510(k) approval for Remplir, its flagship nerve repair product and can now start commercial ...

Vivex Biologics chairman John McCallum breaks down the challenges, costs, and strategies behind bringing medical innovations ...

Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.

The Food and Drug Administration (FDA) has granted accelerated approval to Vanrafia ® (atrasentan) to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies of approved drugs with hidden risks.

President Trump yesterday announced a baseline tariff of 10% on all imported products and higher rates on certain countries ...

The justices handed a win, for now, to the Food and Drug Administration in its rejection of applications from makers of ...

The US Supreme Court largely sided with the Food and Drug Administration in its rejection of applications to sell flavored vaping products, backing actions the agency took during Joe Biden’s ...